help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-127-6-2630
Endocrinology Vol. 127, No. 6 2630-2638
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BOOTH, B. A.
Right arrow Articles by CASCIERI, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BOOTH, B. A.
Right arrow Articles by CASCIERI, M.

Intrinsic Bioactivity of Insulin-Like Growth Factor-Binding Proteins from Vascular Endothelial Cells*

BARBARA A. BOOTH, ROBERT S. BAR, MARY BOES, BRIAN L. DAKE, MARVIN BAYNE and MARGARET CASCIERI

Veterans Administration Hospital, Department of Internal Medicine, Diabetes and Endocrinology Research Center, University of Iowa (B.A.B., R.S.B., M.B., B.L.D.), Iowa City, Iowa 52246; and Merck Sharp and Dohme (M.Ba., M.C.) Rahway, New Jersey 07065

Address requests for reprints to: Dr. Robert S. Bar, Department of Medicine, Veterans Administration Medical Center and Diabetes and Endocrinology Research Center, University of Iowa, Iowa City, Iowa 52246.

Abstract

Conditioned medium from cultured vascular endothelial cells contains material capable of stimulating acute metabolic processes in endothelial cells. The bioactivity of the conditioned medium is not caused by the copurification of known growth factors produced by the cells, in particular plateletderived growth factor, basic fibroblast growth factor, or insulin - like growth factor (IGF)-I/II. We now demonstrate that the bioactivity is directly due to an IGF-binding protein(s) (ECBP) and, further, that the bioactive domain of the binding protein differs from the IGF-binding domain. Binding proteins (BPs) from cultured pulmonary artery endothelial cells were purified by sequential passage over sizing, multiplication-stimulating activity affinity, and hydrophobic columns. BP fractions were separated into those with and those without biological activity. The bioactive binding protein(s) was cross-linked with disuccinimidyl suberate to IGF-I or the recombinant IGF analog [1- 27,Gly4,38-70]IGF-I (Analog). The IGF-I Analog, by itself, had minimal interaction with the type I IGF receptor in cultured microvessel endothelial cells and no intrinsic bioactivity, but did bind with high affinity to ECBP. All free BP and free IGF-I/ Analog were removed from the cross-linked mixture by passage over gel filtration and IGF affinity columns. The cross-linked BP-IGF-I complex did not bind to the type I receptor of cultured endothelial cells, but did stimulate glucose and {alpha}-aminoisobutyric acid uptake in endothelial cells (-2-fold increase); the magnitude of the response was nearly equal to the effect of ECBP or IGF-I alone. The BP-Analog complex also stimulated glucose and a-aminoisobutyric acid uptake, with the magnitude of the response approaching the effect of ECBP alone. The BPAnalog complex also did not react with type I IGF receptors on the cultured endothelial cells. We conclude 1) IGF-BP produced by endothelial cells possess intrinsic biological activity; 2) bioactivity of the BP(s) is retained when the IGF-binding domain of the BP is occupied by IGF-I or an inactive IGF-I analog; and 3) IGF-I bound to the bioactive BP does not react with its receptor and possesses minimal, if any, bioactivity in vitro. (Endocrinology 127: 2630–2638,1990)

Footnotes

* This work was supported by NIH Grants DK-25421 and DK-25295 and V.A. research funds.

Received May 22, 1990.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Delafontaine, Y.-H. Song, and Y. Li
Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels
Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 435 - 444.
[Abstract] [Full Text]


Home page
IOVSHome page
T. Ishibashi, Y. Takagi, K. Mori, S. Naruse, H. Nishino, B. Y. J. T. Yue, and S. Kinoshita
cDNA Microarray Analysis of Gene Expression Changes Induced by Dexamethasone in Cultured Human Trabecular Meshwork Cells
Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3691 - 3697.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Menouny, M. Binoux, and S. Babajko
Role of Insulin-Like Growth Factor Binding Protein-2 and Its Limited Proteolysis in Neuroblastoma Cell Proliferation: Modulation by Transforming Growth Factor-{beta} and Retinoic Acid
Endocrinology, February 1, 1997; 138(2): 683 - 690.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society